219 related articles for article (PubMed ID: 36147475)
21. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
Nuevo-Gonzalez JA; Cano-Ballesteros JC; Lopez B; Andueza-Lillo JA; Audibert L
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S28-31. PubMed ID: 21826411
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
[TBL] [Abstract][Full Text] [Related]
23. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
24. [Hepatoid adenocarcinoma of the stomach].
Wang XL
Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):455-7. PubMed ID: 2471612
[TBL] [Abstract][Full Text] [Related]
25. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
26. [Histopathological and immunohistochemical studies in hepatoid adenocarcinomas of the stomach].
Li X; Zhang D; Le M
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):276-9. PubMed ID: 9388871
[TBL] [Abstract][Full Text] [Related]
27. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
[TBL] [Abstract][Full Text] [Related]
28. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
[TBL] [Abstract][Full Text] [Related]
29. Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Kishimoto T; Nagai Y; Kato K; Ozaki D; Ishikura H
Med Electron Microsc; 2000; 33(2):57-63. PubMed ID: 11810459
[TBL] [Abstract][Full Text] [Related]
30. [Metastatic gastrointestinal hepatoid adenocarcinoma of the liver: a high-grade carcinoma that is easily confused with primary hepatocellular carcinoma].
Lou KX; Fu Y; Wu HY; Wang T; Kwasi ASD; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):710-714. PubMed ID: 32610383
[No Abstract] [Full Text] [Related]
31. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
32. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
[TBL] [Abstract][Full Text] [Related]
33. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
Liu Z; Wang A; Pu Y; Li Z; Xue R; Zhang C; Xiang X; E JY; Bu Z; Bai F; Ji J
Oncogene; 2021 Sep; 40(38):5705-5717. PubMed ID: 34326469
[TBL] [Abstract][Full Text] [Related]
34. [Clinical characteristics and prognosis of hepatoid adenocarcinoma of the stomach].
Yao L; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Feb; 17(2):196-200. PubMed ID: 24577778
[TBL] [Abstract][Full Text] [Related]
35. [A case of hepatic metastasis of gastric hepatoid adenocarcinoma mistaken for primary hepatocellular carcinoma].
Moon JY; Kim GH; Cheong JH; Lee BE; Ryu DY; Song GA
Korean J Gastroenterol; 2012 Oct; 60(4):262-6. PubMed ID: 23089914
[TBL] [Abstract][Full Text] [Related]
36. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach.
Liu X; Cheng Y; Sheng W; Lu H; Xu X; Xu Y; Long Z; Zhu H; Wang Y
Am J Surg Pathol; 2010 Oct; 34(10):1465-71. PubMed ID: 20871221
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations.
Zhao R; Li H; Ge W; Zhu X; Zhu L; Wan X; Wang G; Pan H; Lu J; Han W
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010842
[TBL] [Abstract][Full Text] [Related]
38. Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Yoshizawa J; Ishizone S; Ikeyama M; Nakayama J
BMC Cancer; 2017 May; 17(1):368. PubMed ID: 28545511
[TBL] [Abstract][Full Text] [Related]
39. Hepatoid adenocarcinoma of the stomach - a rare pathological entity.
Muralee M; Ahamed I; Somanathan T; Anila KS
Gulf J Oncolog; 2011 Jan; (9):78-81. PubMed ID: 21177215
[TBL] [Abstract][Full Text] [Related]
40. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
